- Reaction score
- 11,938
If they have better things to do then why are there at least a half a dozen companies spending millions on RD for other male pattern baldness products? We have a whole section here with them listed. Which I should mention are much more complex in treatment and aren't even in phase 3 or 2. I would say a topical, inexpensive and safe male pattern baldness treatment is potentially a billion dollar market. Finasteride is prescription only and I know many people who want nothing to do with it due to the side effects. (ED)
I think by far most men care about their hair and are insecure about it. Most don't know about treatments or aren't willing to take a prescription drug.
I didn't claim that the accountants made the right decision.
Also, the market has changed relative to fifteen years ago, clearly. There are lots of companies working on baldness now. I can't tell you why it's changed.
Whatever company currently owns the patent to RU 58851 might not even realize that it owns the patent. There might be nobody at the company bringing it up and saying "let's commercialize this". It's nobody's baby. Anybody who developed it and worked on it in the 1990s has long moved on.